# ZEB1 and Uveal Melanoma Invasiveness

**Authors:** Maria Zhilnikova, Maria Balantaeva, Sofia Zvereva, Mikhail Biryukov, Vasiliy Atamanov, Julia Poletaeva, Elena Ryabchikova, Olga Stanishevskaya, Dmitryi Chernykh, Natalia Kononova, Olga Koval

PMC · DOI: 10.3390/ijms262110346 · International Journal of Molecular Sciences · 2025-10-24

## TL;DR

This study explores how ZEB1 affects uveal melanoma invasiveness and its connection to VEGF-A and melanocyte differentiation.

## Contribution

The study identifies ZEB1 as a positive regulator of VEGF-A and suggests ZEB1 silencing could aid in treating uveal melanoma.

## Key findings

- ZEB1low cells were found in spindle cell tumors, indicating a link between ZEB1 status and tumor type.
- ZEB1 knockdown blocked VEGF-A production, while anti-VEGF treatment increased ZEB1 levels.
- ZEB1 is a positive regulator of VEGF-A in uveal melanoma cells.

## Abstract

Uveal melanoma (UM) is the most prevalent primary intraocular tumor in adults. Transcription factor ZEB1 is one of the potential master regulators of melanocytes plasticity, because it is recognized as a “driver” of epithelial-to-mesenchymal transitions (EMTs) in carcinomas. We studied the correlation of tumor invasiveness with ZEB1 status and vascular endothelial growth factor/its receptor (VEGF-A/VEGFR2) in UM cells, and also with melanocyte’s differentiation rate. Eight UM cell cultures were characterized by melanosomes content using an ETM. ZEB1, VEGF-A and VEGFR2 levels in UM cells were detected by RT-PCR, Western blot, ELISA and flow cytometry. Effects of siRNA-dependent ZEB1 knockdown on UM cell proliferation and their sensitivity to the VEGF-A inhibitor Eylea (aflibercept) were tested by MTT and in a real-time proliferation assay. UMs with an invasive growth type can maintain a high degree of melanocyte differentiation. All ZEB1low cells were obtained from spindle cell tumors. The sensitivity of UM cells to Eylea inversely correlated with the level of the VEGFR2 receptor. ZEB1 knockdown completely blocked VEGF-A production while anti-VEGF treatment stimulated ZEB1 increase. In UM cell cultures, ZEB1 is a positive regulator of VEGF-A expression. In addition, there is probably a ZEB1 feedback loop that is sensitive to a drop in VEGF-A concentration. The data obtained allow us to consider ZEB1 silencing as an auxiliary link for a combined strategy of killing UM cells.

## Linked entities

- **Genes:** ZEB1 (zinc finger E-box binding homeobox 1) [NCBI Gene 6935], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], KDR (kinase insert domain receptor) [NCBI Gene 3791]
- **Diseases:** uveal melanoma (MONDO:0006486)

## Full-text entities

- **Genes:** ZEB1 (zinc finger E-box binding homeobox 1) [NCBI Gene 6935] {aka AREB6, BZP, DELTAEF1, FECD6, NIL2A, PPCD3}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}
- **Diseases:** spindle cell tumors (MESH:D002277), intraocular tumor (MESH:D064090), carcinomas (MESH:D009369), UM (MESH:C536494)
- **Chemicals:** MTT (MESH:C070243)
- **Cell lines:** UM — Homo sapiens (Human), Uveal melanoma, Cancer cell line (CVCL_8607)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12607405/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12607405/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12607405/full.md

---
Source: https://tomesphere.com/paper/PMC12607405